Physician
Psychiatry
Dr. David L. Dunner, MD
|
|
Give Review
David L. Dunner practices Psychiatry. He researched medicine at Washington University School of Medicine in St. Louis. He has 1 awards "Whos Who in Medicine and Healthcare". David Dunner is a published doctor as well. He has 59 publications published. The latest was: Differentiation of various forms of depression.
Publications
- A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefi...
- Being an Editor of a Psychiatric Journal.
- No Change in Neuropsychological Functioning After Receiving Repetitive Transcranial Magnetic Stimulation Treatment for Major Depression.
- Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice.
- Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects.
- Sexual Functioning in Patients With Recurrent Major Depressive Disorder Enrolled in the PREVENT Study.
- Differentiation of various forms of depression.
- Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study.
- Assessing Rates and Predictors of Tachyphylaxis During the Prevention of Recurrent Episodes of Depression With Venlafaxine ER for Two Years (PREVENT) Study.
- A randomized, double-blind study of increasing or maintaining duloxetine dose in patients without remission of major depressive disorder after initial duloxetine therapy.
- Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression.
- Long-term tolerability and effectiveness of duloxetine in the treatment of major depressive disorder.
- The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
- The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases.
- A comparison of initial duloxetine dosing strategies in patients with major depressive disorder.
- The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.
- Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: a randomized, open-label, pilot study.
- Antidepressant-induced hypomania in treatment-resistant depression.
- Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study.
- Transcranial magnetic stimulation reduces pain in patients with major depression: a sham-controlled study.
- Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study.
- Preventing recurrent depression: long-term treatment for major depressive disorder.
- A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder.
- Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression.
- Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression.
- Basal ganglia shape alterations in bipolar disorder.
- A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression.
- Interactive case conference. First onset of schizophrenia.
- Efficacy and tolerability of controlled-release paroxetine in the treatment of severe depression: post hoc analysis of pooled data from a subset of subjects in four do...
- Interactive case conference: depression, dementia, or pseudodementia?
- Interactive case conference. First episode: depression and panic disorder.
- Bipolar depression.
- Interactive case conference: Depression in the elderly.
- Interactive case conference. Double depression.
- Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients.
- Atypical antipsychotics: efficacy across bipolar disorder subpopulations.
- Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder.
- Cognitive-behavioral analysis system of psychotherapy as a maintenance treatment for chronic depression.
- The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication.
- Brain metabolic alterations in medication-free patients with bipolar disorder.
- Frontal lobe gray matter density decreases in bipolar I disorder.
- Correlates of suicidal behavior and lithium treatment in bipolar disorder.
- Treatment-resistant bipolar disorder: a comparison of rapid cyclers and nonrapid cyclers.
- Treatment considerations for depression in the elderly.
- Anxiety and depression in the elderly: implications for diagnosis and treatment.
- Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma.
- Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
- Efficacy of controlled-release paroxetine in the treatment of late-life depression.
- Drug interactions of lithium and other antimanic/mood-stabilizing medications.
- Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
- Duloxetine in treatment of anxiety symptoms associated with depression.
- Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination.
- Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression.
- Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination.
- Dysthymic disorder: treatment with citalopram.
- Six-year perspectives on the safety and tolerability of nefazodone.
- Improved Health-Related Quality of Life and Reduced Productivity Loss After Treatment With Bupropion Sustained Release: A Study in Patients With Major Depression.
- Treatment Options in Severe Psychotic Depression.
Schools
Washington Center School of Medicine
Philadelphia General Hospital
Barnes Hospital Wash
Doctors Specialties
- Psychiatry
Accepted Insurances
Awards
- Whos Who in Medicine and Healthcare
Education
-
Washington University - Barnes-Jewish Hospital -
Washington University -
Washington University School of Medicine in St. Louis
Helpful Reviews
Similar Doctors
|
Dr. Robert G. Thilo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin L. Sloan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cuc T. Nguyen, MD |
|
|
Dr. Christina M. Demopulos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edyth D. Phillips, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Clark T. Ballard Jr., MS
This Doctor is OpenDoctor Recommended.
|